An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

Background: In the United Kingdom (UK), a cell-based quadrivalent influenza vaccine (QIVc) and a recombinant vaccine (QIVr) are recommended for eligible adults under 65 years. The objective of this analysis was to determine the potential cost-effectiveness of QIVc compared to QIVr for this age group...

Descripción completa

Detalles Bibliográficos
Autores principales: Maschio, Michael, Kohli, Michele A., Ashraf, Mansoor, Drummond, Michael F., Weinstein, Milton C., Mould-Quevedo, Joaquin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025244/
https://www.ncbi.nlm.nih.gov/pubmed/35455348
http://dx.doi.org/10.3390/vaccines10040599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025244/
https://www.ncbi.nlm.nih.gov/pubmed/35455348
http://dx.doi.org/10.3390/vaccines10040599

Ejemplares similares